Regeneron Pharmaceuticals REGN PEG ratio
PEG ratio at other companies
Other financials
Where this comes from
Calculated from Regeneron Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Regeneron Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Regeneron Pharmaceuticals's peg ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Regeneron Pharmaceuticals's PEG ratio?
- Regeneron Pharmaceuticals (REGN) reported PEG ratio of 8.6× in Q4 2025.
- How has Regeneron Pharmaceuticals's PEG ratio changed year-over-year?
- Regeneron Pharmaceuticals's PEG ratio increased by 463.4% year-over-year, from 1.5× to 8.6×.
- What is the long-term trend for Regeneron Pharmaceuticals's PEG ratio?
- Over 3 years (2020 to 2025), Regeneron Pharmaceuticals's PEG ratio has grown at a 237.5% compound annual growth rate (CAGR), from 0.2× to 8.6×.
- What does PEG ratio mean?
- The P/E ratio adjusted for how fast earnings are growing.
- How do you interpret PEG ratio?
- Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
- How does PEG ratio compare across companies?
- A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.